CO129 Novel Endpoints in Chronic Kidney Disease (CKD): Trends in the Use of eGFR Slope and Proteinuria As Efficacy Endpoints in Clinical Trials
Abstract
Authors
A. Robert J. Beggs
A. Robert J. Beggs
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now